| Financial Year |
March 31 2023 |
| Monetary Funds |
116,263,593.99 |
| Held-for-trading Financial Assets |
111,158,394.47 |
| Notes Receivable |
134,684,445.98 |
| Accounts Receivable |
386,056,300.32 |
| Advances to Suppliers |
20,440,153.58 |
| Other Receivables |
7,491,275.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
256,376,831.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
96,322,159.59 |
| Total Current Assets |
1,165,622,752.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,783,325.17 |
| Long-term Equity Investment |
21,333,298.24 |
| Investment Properties |
-- |
| Fixed Assetes |
273,406,209.07 |
| Under-construction Projects |
124,263,854.30 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
102,295,974.32 |
| R&D expenses |
-- |
| Goodwill |
14,302,661.57 |
| Long-Term Deferred and Prepaid Expenses |
11,109,102.95 |
| Deferred Income Tax Assets |
10,053,371.42 |
| Other Non-Current Assets |
16,845,604.22 |
| Sub-Total of Non-Current Assets |
597,676,995.67 |
| Total Assets |
1,763,299,748.56 |
| Short-Term Loans |
57,978,633.50 |
| Trading Financial liabilities |
251,595.00 |
| Notes Payable |
80,296,121.64 |
| Accounts Payable |
207,943,846.43 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,125,421.17 |
| Taxes Payable |
4,344,735.40 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
81,041,100.67 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,741,029.21 |
| Other Current Liabilities |
2,456,785.39 |
| Sub-Total of Current Liabilities |
458,753,468.99 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,026,058.63 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
22,196,869.66 |
| Total Liabilities |
480,950,338.65 |
| Paid-In Capital(Or Share Stock) |
474,557,935.00 |
| Capital Surplus |
1,019,814,284.40 |
| Surplus Reserve |
35,768,016.59 |
| LESS:Treasury Stock |
77,435,175.00 |
| Undistributed Profits |
-190,638,382.24 |
| Minority Stockholder's Interest |
23,403,856.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,258,945,553.23 |
| Owner's Equity（Stockholder's Equity） |
1,282,349,409.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,763,299,748.56 |
